PWM
IMNM icon

Palumbo Wealth Management’s Immunome IMNM Stock Holding History

Palumbo Wealth Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$692K Buy
32,659
+608
+2% +$13K 0.14% 106
2026
Q1 		$701K Buy
32,051
+1,073
+3% +$23.9K 0.17% 92
2025
Q4 		$665K Buy
30,978
+9,134
+42% +$160K 0.16% 98
2025
Q3 		$256K Buy
+21,844
New +$217K 0.08% 153

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Palumbo Wealth Management's IMNM Position: Q2 2026 in Review

Palumbo Wealth Management increased its Immunome (IMNM) stake by 1.9% in Q2 2026, buying an estimated $13K and bringing the position to 32,659 shares worth $692K. The position accounts for 0.14% of the portfolio, ranked #106.

Palumbo Wealth Management first reported a position in IMNM in Q3 2025 and has held it in 4 quarters since. The position peaked at $701K in Q1 2026. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Palumbo Wealth Management held 32,659 shares of Immunome worth $692K as of Q2 2026.
  • Palumbo Wealth Management bought 608 Immunome shares in Q2 2026, an estimated $13K.
  • Immunome made up 0.14% of Palumbo Wealth Management's portfolio in Q2 2026, its #106 holding.
  • Palumbo Wealth Management first reported a position in Immunome in Q3 2025 and has held it in 4 quarters since.
  • Palumbo Wealth Management's Immunome position peaked at $701K in Q1 2026.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Palumbo Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.